MannKind Corporation

General ticker "MNKD" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $1.5B (TTM average)

MannKind Corporation follows the US Stock Market performance with the rate: 13.8%.

Estimated limits based on current volatility of 1.9%: low 5.57$, high 5.78$

Factors to consider:

  • Total employees count: 407 (-1.7%) as of 2024
  • Top business risk factors: Geopolitical risks, Market competition, Regulatory and compliance, Supply chain disruptions, Acquisition/divestiture risks
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [4.68$, 8.59$]
  • 2025-12-31 to 2026-12-31 estimated range: [4.46$, 8.26$]

Financial Metrics affecting the MNKD estimates:

  • Positive: with PPE of 41.3 at the end of fiscal year the price was very low
  • Positive: Operating profit margin, % of 25.42 > 18.64
  • Negative: negative Industry operating cash flow (median)
  • Negative: Investing cash flow per share per price, % of -5.33 <= -4.48
  • Negative: 0.79 < Interest expense per share per price, % of 2.09
  • Negative: Shareholder equity ratio, % of -20.01 <= 18.93

Similar symbols

Short-term MNKD quotes

Long-term MNKD plot with estimates

Financial data

YTD 2023-12-31 2024-12-31
Operating Revenue $198.96MM $285.50MM
Operating Expenses $190.28MM $212.92MM
Operating Income $8.68MM $72.59MM
Non-Operating Income $-19.05MM $-42.07MM
Interest Expense $25.16MM $37.98MM
R&D Expense $31.28MM $45.89MM
Income(Loss) $-10.38MM $30.52MM
Taxes $1.56MM $2.93MM
Profit(Loss)* $-11.94MM $27.59MM
Stockholders Equity $-246.17MM $-78.82MM
Inventory $28.55MM $27.89MM
Assets $475.20MM $393.84MM
Operating Cash Flow $34.09MM $42.51MM
Capital expenditure $42.44MM $9.69MM
Investing Cash Flow $-1.99MM $-96.65MM
Financing Cash Flow $136.61MM $-137.27MM
Earnings Per Share** $-0.04 $0.10

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.